Pettegrew, J. W., W. E. Klunke, and K. Panchalingam, «Clinical and Biochemical Effects of Acetyl-L–Carnitine in Alzheimer’s Disease», Neurobiology of Aging 16 (1998): 1–4.
Rai, G., et al. «Double-Blind, Placebo-Controlled Study of Acetyl-L–Carnitine in Patients with Alzheimer’s Dementia», Current Medical Research and Opinion 11 (1990): 638–47.
Salvioli, G., and M. Neri, «L-Acetyl carnitine Treatment of Mental Decline in the Elderly», Drugs Under Experimental and Clinical Research 20 (1994): 169–76.
Sano, M., et al. «Double-Blind Parallel Pilot Study of Acetyl Levocarnitine in Patients with Alzheimer’s Disease», Archives of Neurology 49 (1992): 1137–41.
Spagnoli, A., et al. «Long-Term Acetyl-L–Carnitine Treatment in Alzheimer’s Disease», Neurology 41 (1991): 1726–32.
Tempesta, E., et al. «Role of Acetyl-L–Carnitine in the Treatment of Cognitive Deficit in Chronic Alcoholism», International Journal of Clinical Pharmacological Research 10 (1990): 101–07.
Tempesta, E., et al. «L-Acetylcarnitine in Depressed Elderly Subjects. A Cross-over Study vs. Placebo», Drugs Under Experimental and Clinical Research 10 (1990): 101–07.
Thai, L. J., et al. «A One Year Multicenter Placebo-Controlled Study of Acetyl-L–Carnitine in Patients with Alzheimer’s Disease», Neurology 47 (1996): 705–11.
Marangon, K., et al. «Comparison of the Effect of Alpha-Lipoic Acid and Alpha-Tocopherol Supplementation on Measures of Oxidative Stress», Free Radical Biology and Medicine 27(1999): 1114–21.
Packer, L., H.J. Tritschler, and K. Wessel, «Neuroprotection by the Metabolic Antioxidant Alpha-Lipoic Acid», Free Radical Biology and Medicine 22 (1997): 359–78.
Packer, L., E. H. Witt, and H. J. Tritschler, «Alpha-Lipoic as a Biological Antioxidant», Free Radical Biology and Medicine 79 (1995): 227–50.
Poon, Н. F., et al. «Proteomic Analysis of Specific Brain Proteins in Aged SAMP8 Mice Treated with Alpha-Lipoic Acid: Implications for Aging and Age-Related Neuro-degenerative Disorders», Neurochemistry International 46, no. 2 (January 2005): 159–68.
Tirosh, O., et al. «Neuroprotective Effects of Alpha-Lipoic Acid and Its Positively Charged Amide Analogue», Free Radical Biology and Medicine 26 (1999): 1418–26.
Ziegler, D., et al. «Treatment of Symptomatic Diabetic Peripheral Neuropathy with the Antioxidant Alpha-Lipoic Acid. A Three-Week Multicentre Randomized Controlled Trial (ALADIN Study)», Diabetologia 38 (1995): 1425–33.
Baggio, E., et al. «Italian Multicenter Study on the Safety and Efficacy of Coenzyme Q10 as Adjunctive Therapy in Heart Failure», Molecular Aspects of Medicine 15 (Suppl.) (1994): 287–94.
Chopra, R. K., et al. «Relative Bioavailability of Coenzyme Q10 Formulations in Human Subjects», International Journal for Vitamin and Nutrition Research 68 (1998): 109–13.
Crane, F. L, I. L. Sun, and E. E. Sun, «The Essential Functions of Coenzyme Q», Clinical Investigator 71 (Suppl.) (1993): S55–59.
Folkers, K., et al. «Lovastatin Decreases Coenzyme Q Levels in Humans», Proceedings of the National Academy of Science 87 (1990): 8931–34.
Hanaki, Y., et al. «Coenzyme Q10 and Coronary Artery Disease», Clinical Investigator7. (Suppl.) (1993): SI 12–15.
Matthews, R. Т., et al. «Coenzyme Q10 Administration Increases Mitochondrial Concentrations and Exerts Neuroprotective Effects», Proceedings of the National Academy of Science 95(1998): 8892–97.
Shults, C. W, et al. «Pilot Trial of High Dosages of Coenzyme Q10 in Patients with Parkinson’s Disease», Experimental Neurology 188, no. 2 (August 2004): 491–94.
Spigset, O., «Reduced Effect of Warfarin Caused by Ubidecarenone», Lancet 344 (1994): 1372–73.